Ceek.jp Altmetrics (α ver.)
  1. ホーム
  2. Twitter
  3. Yuichi J. Shimada, MD, M

Yuichi J. Shimada, MD, M (@yuichishimada)

投稿一覧（最新100件）

1 0 0 0 OA Effects of Septal Reduction Therapy on Acute Cardiovascular Events and All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy

Our paper on cardiovascular effects of septal reduction therapy in patients with hypertrophic cardiomyopathy has been published in International Heart Journal誌に、肥大型心筋症患者における中隔縮小療法の心血管イベントに対する効果を検証した論文を発表しました https://t.co/pbez2GvAyv

2 0 0 0 OA Endotyping in Heart Failure ― Identifying Mechanistically Meaningful Subtypes of Disease ―

Published a review article on endotyping (or molecular subtying) in patients with heart failure in Circulation Journal誌に心不全患者における分子的サブタイプについての論説を掲載していただきました。 https://t.co/2kfZlG1AKL

3 0 0 0 OA Clinical Correlates and Prognostic Value of Elevated Right Atrial Pressure in Patients With Hypertrophic Cardiomyopathy

My last-authored article on the prognostic value of right-sided heart failure in hypertrophic cardiomyopathy has just been published in Circulation Journal. 肥大型心筋症における右心不全の予後予測能を示した最終筆者論文がCirculation Journalに掲載されました。 https://t.co/pEChZmQCVH

1 0 0 0 OA Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin – Insights From the ENGAGE AF-TIMI 48 Trial –

ENGAGE AF: "Edoxaban had an enhanced relative efficacy and safety vs. warfarin in East Asia compared with Japan." https://t.co/gpZ8DqzhcH

お気に入り一覧（最新100件）

フォロー（105ユーザ）の投稿一覧（直近7日間）

フォロワー（430ユーザ）の投稿一覧（直近7日間）